Venetoclax-Resistant MV4-11 Leukemic Cells Activate PI3K/AKT Pathway for Metabolic Reprogramming and Redox Adaptation for Survival.

Antioxidants (Basel) · 2022 · PMC8944541 · PMID 35326111

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The highly significant metabolite with its expression index in PCA analysis revealed the change in metabolite accumulation in MV4-11 cells, ABT199-R cells, and ABT199-R cells treated with PKI-402 ( Figure 3 E).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.